Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan

Mutation Research - Reviews in Mutation Research

Volumn 386, Issue 3, 1997, Pages 197-207

  Chiou, Hung Yi ^a   Hsueh, Yu Mei ^a   Hsieh, Ling Ling ^b   Hsu, Ling I ^c   Yi Hsiang, Hsu ^c   Hsieh, Fang I ^c   Wei, Min Li ^c   Chen, Hsiang Chih ^c   Yang, Hui Ting ^c   Leu, Lan Chin ^d   Chu, Tzu Hsien ^c   Chen Wu, Chuan ^a   Yang, Mo Hsiung ^d   Chen, Chien Jen ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Arsenic; Body retention; Glutathione S transferase; Methylation

Indexed keywords

ARSENIC; CACODYLIC ACID; DNA; DRINKING WATER; GLUTATHIONE TRANSFERASE; METHANEARSONIC ACID;

BIOACCUMULATION; BLOOD LEVEL; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HAIR ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; NAIL; PRIORITY JOURNAL; REVIEW; TAIWAN; TOE; URINE LEVEL;

EID: 0030790951     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(97)00005-7     Document Type: Review

References (49)

1. World Health Organization (1981) Environmental Health Criteria 18: Arsenic, WHO, Geneva, pp. 18-22.
2. U.S. Public Health Service (1989) Toxicological Profile for Arsenic, U.S. Public Health Service, Washington DC, pp. 9-67.
3. A.H. Smith, C. Hopehayn-Rich, M.N. Bates, H.M. Goeden, I. Hertz-Picciotto, H.M. Duggan, R. Wood, M.J. Kosnett, M.T. Smith, Cancer risks from arsenic in drinking water, Environ. Health Perspect. 97 (1992) 259-267.
4. International Agency for Research on Cancer (1987) Evaluation of carcinogenic risks to humans: Supplement 7, IARC, Lyon, pp. 100-106.
5. W.P. Tseng, Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic, Environ. Health Perspect. 19 (1968) 109-119.
6. C.J. Chen, M.M. Wu, S.S. Lee, J.D. Wang, S.H. Cheng, H.Y. Wu, Atherogenicity and carcinogenicity of high-arsenic artesian well water: multiple risk factors and related malignant neoplasms of blackfoot disease, Arteriosclerosis 8 (1988) 452-460.
7. H.Y. Chiou, Y.M. Hsueh, K.F. Liaw, S.F. Horng, M.H. Chiang, Y.S. Pu, J.S.-N. Lin, C.H. Huang, C.J. Chen, Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan, Cancer Res. 55 (1995) 1296-1300.
8. C.J. Chen, Y.C. Chuang, T.M. Lin, H.Y. Wu, Malignant neoplasms among residents of a blackfoot disease endemic area in Taiwan: high arsenic artesian well water and cancers, Cancer Res. 45 (1985) 5895-5899.
9. C.J. Chen, Y.C. Chuang, S.L. You, T.M. Lin, H.Y. Wu, A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan, Br. J. Cancer 53 (1986) 399-405.
10. C.J. Chen, M.M. Wu, T.L. Kuo, Arsenic and cancers, Lancet 20 (1988) 414-415.
11. C.J. Chen, C.W. Chen, M.M. Wu, T.L. Kuo, Cancer potential in liver, lung, bladder, and kidney due to ingested inorganic arsenic in drinking water, Br. J. Cancer 66 (1992) 888-892.
12. 74As) in humans following oral ingestion, Toxicol. Appl. Pharmacol. 50 (1979) 319-322.
13. M. Vahter, E. Marafante, Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits, Chem.-Biol. Interact. 47 (1983) 29-44.
14. 74As-dimethyl-arsenic acid in mice and rats, Environ. Contam. Toxicol. 13 (1984) 259-264.
15. D.J. Thompson, A chemical hypothesis for arsenic methylation in mammals, Chem.-Biol. Interact. 88 (1993) 89-114.
16. J.P. Buchet, R. Lauwerys, H. Roels, Comparison of the urinary excretion of arsenic metabolites after a single dose of sodium arsenite monomethyl arsonate or dimethyl arsinate in man, Int. Arch. Occup. Environ, Health 48 (1981) 71-79.
17. E. Marafante, M. Vahter, J. Envall, The role of the methylation in the detoxification of arsenate in the rabbit, Chem.-Biol. Interact. 56 (1985) 225-238.
18. E. Marafante, M. Vahter, Solubility, retention and metabolism of intratracheally and orally administered inorganic arsenic compounds in the hamster, Environ. Res. 42 (1987) 72-82.
19. M. Vahter, Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats, Environ. Res. 25 (1981) 286-293.
20. M. Vahter, E. Marafante, Reduction and binding of arsenate in marmoset monkeys, Arch. Toxicol. 57 (1985) 119-124.
21. M. Vahter, R. Couch, B. Nermell, R. Nilsson, Lack of methylation of inorganic arsenic in the chimpanzee, Toxicol. Appl. Pharmacol. 133 (1995) 262-268.
22. H. Yamauchi, K. Takahashi, M. Mashiko, Y. Yamamura, Biological monitoring of arsenic exposure of gallium arsenide-and inorganic arsenic-exposed workers by determination of inorganic arsenic and its metabolites in urine and hair, Am. Ind. Hyg. Assoc. J. 50 (1989) 606-612.
23. M. Garland, J.S. Morris, B.A. Rosner, M.J. Stampfer, V.L. Spate, C.J. Baskett, W.C. Willett, D.J. Hunter, Tocnail trace element levels as biomarkers: reproducibility over a 6-year period, Cancer Epidemiol. Biomark. Prev. 2 (1993) 493-497.
24. P. Board, M. Coggan, P. Johnston, V. Ross, T. Suzuki, G. Webb, Genetic heterogeneity of the human glutathione transferase: a complex of gene families, Pharmacol. Ther. 48 (1990) 357-369.
25. D.A. Bell, J.A. Tayler, D.F. Paulson, C.N. Robertson, J.L. Mohler, G.W. Lucier, Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer, J. Natl. Cancer Inst. 85 (1993) 1159-1163.
26. J. Brockmoller, R. Kerb, N. Drakoulis, M. Nitz, I. Roots, Glutathione and phenotype of glutathione S-transferase class (isoenzymes (and (in lung cancer patients and controls, Cancer Res. 53 (1993) 1004-1011.
27. J. Brockmoller, R. Kerb, N. Drakoulis, B. Staffeldt, I. Root, Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study, Cancer Res. 54 (1994) 4103-4111.
28. G. Chenevix-Trench, J. Young, M. Coggan, P. Board, Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset, Carcinogenesis 16 (7) (1995) 1655-1657.
29. Y.H. Liu, J. Taylor, P. Linko, G.W. Lucier, C.L. Thompson, Glutathione S-transferase μ in human lymphocyte and liver: role in modulating formation of carcinogen-derived DNA adducts, Carcinogenesis 12 (1991) 2269-2275.
30. S. Zhong, A.F. Howie, B. Ketterer, J. Tayler, J.D. Hayes, G.J. Beckeet, C.G. Wathen, C.R. Wolf, N.K. Spurr, Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility, Carcinogenesis 12 (1991) 1533-1537.
31. S. Zhong, A.H. Wyllie, D. Barnes, C.R. Wolf, N.K. Spurr, Relationship between the GST M1 genetic polymorphism and susceptibility to bladder, breast and colon cancer, Carcinogenesis 14 (1993) 1821-1824.
32. H.M.H. Adrian, D. Fitzgerald, A. Smith, B. Bowers, P. Jones, A.A. Fryer, L. Zhao, J. Alldersea, R.C. Strange, Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours, Lancet 343 (1994) 266-267.
33. J.P. Buchet, R. Lauwerys, Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observations in man, Arch. Toxicol. 57 (1985) 125-129.
34. J.P. Buchet, R. Lauwerys, Study of factors influencing the in vivo methylation of inorganic arsenic in rats, Toxicol. Appl. Pharmacol. 91 (1987) 65-74.
35. E.C. Tore, J.J.M. De Goeij, J. Bacso, Y.D. Cheng, L. Kinova, J. Matsubara, S. Niese, T. Sato, G.R. Wesenberg, Y. Muramatsu, R.M. Parr, The significance of hair mineral analysis as a means for assessing internal body burdens of environmental pollutants: results from an IAEA co-ordinated research programme, J. Radioan. Nucl. Ch. Ar. 167 (1993) 413-421.
36. S. Pemble, K.R. Schroeder, S.R. Spencer, D.J. Meyer, E. Hallier, H.M. Bolt, B. Ketterer, J.B. Tayler, Human glutathione S-transferase Theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism, Biochem. J. 300 (1994) 271-276.
37. B. Georis, A. Cardenas, J.P. Buchet, R.R. Lauwerys, Inorganic arsenic methylation by rat tissue slices, Toxicology 63 (1990) 73-84.
38. M. Vahter, E. Marafante, Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenic in the rabbit, Toxicol. Lett. 37 (1987) 41-46.
39. J.P. Buchet, R. Lauwerys, H. Roels, Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium meta arsenite by volunteers, Int. Arch. Occup. Environ. Health 48 (1981) 111-118.
40. J.G. Farmer, L.R. Johnson, Assessment of occupational exposure to inorganic arsenic based on urinary concentrations and speciation of arsenic, Br. J. Ind. Med. 47 (1990) 342-348.
41. D.A. Kalman, J. Hughes, G.V. Belle, T. Burbacher, D. Bolgiano, K. Coble, N.K. Mottet, L. Polissar, The effect of variable environmental arsenic contamination on urinary concentrations of arsenic species. Environ. Health Perspect. 89 (1990) 145-151.
42. Cebrian, M.E., A. Albores, G. Garcia-Vargas and L.M. Del Razo (1994) Chronic arsenic poisoning in humans: the case of Mexico, in: J.O. Nriagu (Ed.), Arsenic in the Environment. Part II: Human Health and Ecosystem Effects, John Wiley & Sons, New York, pp. 93-107.
43. G.F. Gordon, Sex and age related differences in trace element concentrations in hair, Sci. Total Environ. 42 (1985) 137-147.
44. Y. Takagi, S. Matsuda, S. Imai, Y. Ohmori, T. Masuda, J.A. Vinson, M.C. Mehra, B.K. Puri, A. Kaniewski, Trace elements in human hair: an international comparison, Bull. Environ. Contam. Toxicol. 36 (1986) 793-800.
45. J.P. Buchet, R. Lauwerys, Role of thiols in the in vitro methylation of inorganic arsenic by rat liver cytosol, Biochem. Pharmacol. 37 (1988) 31-49.
46. T.M.T. Mulders, H.J. Keizer, D.D. Breimer, G.J. Mulder, In vivo characterization and modulation of the glutathione/glutathione S-transferase system in cancer patients, Drug Metab. Rev. 27 (1995) 191-229.
47. J.L. Henry, C.Y. Huan, D.A. Bernstein, W. Hsiao, B.K. Lin, S. Hardy, Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility, Carcinogenesis 15 (1994) 1077-1081.
48. H.H. Nelson, J.K. Wiencke, D.C. Christiani, T.J. Cheng, Z.-F. Zuo, B.S. Schwartz, B.-K. Lee, M.R. Spitz, M. Wang, X. Xu, K.T. Kelsey, Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta, Carcinogenesis 16 (1995) 1243-1245.
49. W.P. Tseng, Title to be provided, J. Natl. Cancer Inst. 40 (1968) 453-463.